Pete Meyers
Director/Board Member bei IMMUTEP LIMITED
Vermögen: 811 755 $ am 31.03.2024
Profil
Peter A.
Meyers is currently the Non-Executive Deputy Chairman at Immutep Ltd.
and the Chairman & President at Thomas M Brennan Memorial Foundation, Inc. He is also a Director at Hospice, Inc. (Iowa), East End Hospice, Inc., and Slayback Pharma LLC.
Previously, Mr. Meyers held positions such as Managing Director at Deutsche Bank Securities, Inc., Chief Financial Officer at Motif BioSciences, Inc., Chief Financial Officer & Treasurer at TetraLogic Pharmaceuticals Corp., and Chief Financial Officer at Eagle Pharmaceuticals, Inc. He also worked as a Vice President-Health Care Mergers & Acquisition at Dillon, Read & Co., Inc. and as the Chief Financial & Accounting Officer at Motif Bio Plc.
Mr. Meyers completed his undergraduate degree at Boston College in 1991 and obtained an MBA from Columbia Business School in 1995.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IMMUTEP LTD
0,28% | 03.10.2023 | 3 274 395 ( 0,28% ) | 811 755 $ | 31.03.2024 |
Aktive Positionen von Pete Meyers
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUTEP LIMITED | Director/Board Member | 12.02.2014 |
| Thomas M Brennan Memorial Foundation, Inc. | Chairman | 01.09.2001 |
| East End Hospice, Inc. | Director/Board Member | - |
Slayback Pharma LLC
 Slayback Pharma LLC Pharmaceuticals: GenericHealth Technology Slayback Pharma LLC is a specialty pharmaceutical company focused on developing, manufacturing and sourcing of complex generic pharmaceutical products, with a specific emphasis on complex injectables and other non-solid oral products. The company is headquartered in Princeton Junction, NJ. | Director of Finance/CFO | - |
Hospice, Inc. (Iowa)
 Hospice, Inc. (Iowa) Medical/Nursing ServicesHealth Services Hospice, Inc. is a private company based in Ottumwa, IA and has subsidiaries in United States. The company provides hospice care. | Director/Board Member | - |
Ehemalige bekannte Positionen von Pete Meyers
| Unternehmen | Position | Ende |
|---|---|---|
| EAGLE PHARMACEUTICALS, INC. | Director of Finance/CFO | 29.10.2020 |
| MOTIF BIO PLC | Director of Finance/CFO | 17.01.2017 |
Motif BioSciences, Inc.
 Motif BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Motif BioSciences, Inc. develops antibiotics designed to be effective against serious and life-threatening infections. The company was founded on June 8, 2004 and is headquartered in New York, NY. | Director of Finance/CFO | 01.01.2017 |
| TETRALOGIC PHARMACEUTICALS CORPORATION | Director of Finance/CFO | 01.03.2016 |
| ░░░░░░░░ ░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Pete Meyers
| Boston College | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| TETRALOGIC PHARMACEUTICALS CORPORATION | Health Technology |
| EAGLE PHARMACEUTICALS, INC. | Health Technology |
| IMMUTEP LIMITED | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Deutsche Bank Securities, Inc.
 Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve. | Finance |
Motif BioSciences, Inc.
Motif BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Motif BioSciences, Inc. develops antibiotics designed to be effective against serious and life-threatening infections. The company was founded on June 8, 2004 and is headquartered in New York, NY. | Health Technology |
| Dillon, Read & Co., Inc. | Finance |
Hospice, Inc. (Iowa)
Hospice, Inc. (Iowa) Medical/Nursing ServicesHealth Services Hospice, Inc. is a private company based in Ottumwa, IA and has subsidiaries in United States. The company provides hospice care. | Health Services |
| Thomas M Brennan Memorial Foundation, Inc. | |
Slayback Pharma LLC
Slayback Pharma LLC Pharmaceuticals: GenericHealth Technology Slayback Pharma LLC is a specialty pharmaceutical company focused on developing, manufacturing and sourcing of complex generic pharmaceutical products, with a specific emphasis on complex injectables and other non-solid oral products. The company is headquartered in Princeton Junction, NJ. | Health Technology |
| East End Hospice, Inc. | |
Motif Bio Plc
 Motif Bio Plc Pharmaceuticals: MajorHealth Technology Motif Bio Plc is a clinical stage biopharmaceutical company, which engages in the development and commercialization of pharmaceutical formulations. The company focuses on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. It offers Iclaprim, a novel diaminopyrimidine antibiotic that inhibits an essential bacterial enzyme called dihydrofolate reductase. The company was founded by Jonathan E. Gold on November 20, 2014 and is headquartered in Princeton, NJ. | Health Technology |
